Global pharmaceutical giant Sandoz is undergoing a profound strategic evolution, shifting its long-term commercial anchor away from traditional small-molecule generics…
Read More
Sandoz and mAbxience Forge Strategic Global Partnership to Develop and Commercialize Emicizumab Biosimilar for Haemophilia A
The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…
Read More
FDA Approves Langlara, an Interchangeable Biosimilar for Diabetes Management, Expanding Patient Access and Treatment Options
Sunshine Lake Pharma, Lannett Company, and its wholly owned subsidiary Lanexa Biologics have achieved a significant milestone in diabetes care…
Read More
Teva Pharmaceutical Secures FDA Approval for Ponlimsi Biosimilar to Prolia, Advances Xolair Biosimilar Applications in US and EU
Teva Pharmaceutical has announced a significant milestone in its biosimilar portfolio with the U.S. Food and Drug Administration (FDA) granting…
Read MoreYOU MAY HAVE MISSED
